Cure My Disease

Don't miss your cure!

 Log in / Sign up

New psoriasis drug shows promise for kids in Head-to-Head trial

NCT ID NCT06425549

Ongoing Disease control Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This study tests a new medicine called bimekizumab against an existing one (ustekinumab) for children and teens aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if bimekizumab works better at clearing skin symptoms. About 168 participants will receive injections and be monitored for improvement and side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE PLAQUE PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MODERATE TO SEVERE PLAQUE PSORIASIS

Contacts and locations

Locations

  • Ps0021 20033

    Nagoya, Japan

  • Ps0021 20071

    Nagasaki, Japan

  • Ps0021 20337

    Shimotsuga-gun, Japan

  • Ps0021 40023

    Erlangen, Germany

  • Ps0021 40085

    Pisa, Italy

  • Ps0021 40091

    Nowa Sól, Poland

  • Ps0021 40121

    Brussels, Belgium

  • Ps0021 40138

    Bonn, Germany

  • Ps0021 40177

    Münster, Germany

  • Ps0021 40249

    Kiel, Germany

  • Ps0021 40334

    Wroclaw, Poland

  • Ps0021 40356

    Dresden, Germany

  • Ps0021 40440

    Ancona, Località Torrette, Italy

  • Ps0021 40515

    Berlin, Germany

  • Ps0021 40567

    Roma, Italy

  • Ps0021 40625

    Lodz, Poland

  • Ps0021 40645

    Frankfurt am Main, Germany

  • Ps0021 40737

    Rzeszów, Poland

  • Ps0021 40738

    Wroclaw, Poland

  • Ps0021 40740

    Bad Bentheim, Germany

  • Ps0021 40741

    Bialystok, Poland

  • Ps0021 40743

    Szczecin, Poland

  • Ps0021 40744

    Kaposvár, Hungary

  • Ps0021 40745

    Szeged, Hungary

  • Ps0021 40746

    Debrecen, Hungary

  • Ps0021 40747

    Mainz, Germany

  • Ps0021 40748

    Plzen-bory, Czechia

  • Ps0021 40749

    Catania, Italy

  • Ps0021 40750

    Alicante, Spain

  • Ps0021 40751

    Esplugues de Llobregat, Spain

  • Ps0021 40752

    Granada, Spain

  • Ps0021 40758

    Hamburg, Germany

  • Ps0021 40832

    Lodz, Poland

  • Ps0021 50084

    Charleston, South Carolina, 29425, United States

  • Ps0021 50161

    Los Angeles, California, 90045, United States

  • Ps0021 50162

    Fountain Valley, California, 92708, United States

  • Ps0021 50196

    Northridge, California, 91325, United States

  • Ps0021 50201

    Arlington, Texas, 76011, United States

  • Ps0021 50344

    Indianapolis, Indiana, 46250, United States

  • Ps0021 50355

    Dallas, Texas, 75235, United States

  • Ps0021 50357

    St. John's, Canada

  • Ps0021 50618

    Mississauga, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.